Filing Details

Accession Number:
0001209191-18-047212
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-16 19:31:42
Reporting Period:
2018-08-14
Accepted Time:
2018-08-16 19:31:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1600132 Bellerophon Therapeutics Inc. BLPH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277994 P L Iv Fund Entrepreneurs Venrock C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1277997 P L Iv Associates Venrock C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1305238 Venrock Management Iv, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1305239 Venrock Partners, L.p. C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1305240 Venrock Partners Management, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1305243 Vef Management Iv, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1602263 Vhcp Management Ii, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1602264 Venrock Healthcare Capital Partners Ii, L.p. C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1615979 Y Bong Koh C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
1615983 Vhcp Co-Investment Holdings Ii, Llc C/O Venrock
3340 Hillview Avenue
Palo Alto CA 94304
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-14 190,977 $0.65 6,202,770 No 4 P Indirect By funds
Common Stock Acquisiton 2018-08-15 272,000 $0.65 6,474,770 No 4 P Indirect By funds
Common Stock Acquisiton 2018-08-16 66,393 $0.65 6,541,163 No 4 P Indirect By funds
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By funds
No 4 P Indirect By funds
No 4 P Indirect By funds
Footnotes
  1. This Form 4 is the first of two Form 4s being filed to report the beneficial ownership of the following Reporting Persons: Venrock Associates IV, LP, Venrock Partners, LP, Venrock Entrepreneurs Fund IV, LP, Venrock Management IV, LLC, Venrock Partners Management, LLC, VEF Management IV, LLC, Venrock Healthcare Capital Partners II, LP, VHCP Management II, LLC, VHCP Co-Investment Holdings II, LLC, Bong Koh and Nimish Shah. Two Form 4s are being filed because each form can report a maximum of 10 reporting persons.
  2. Consists of (i) 173,617 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 17,360 shares purchased by VHCP Co-Investment Holdings III, LLC.
  3. Consists of (i) 247,275 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 24,725 shares purchased by VHCP Co-Investment Holdings III, LLC.
  4. Consists of (i) 60,358 shares purchased by Venrock Healthcare Capital Partners III, LP and (ii) 6,035 shares purchased by VHCP Co-Investment Holdings II, LLC.